R. G. Wiewrodt (Mainz, Germany), A.-P. Meert (Brussels, Belgium)
Heparins inhibit lung cancer cells proliferation in vitro
Y. Carmazzi, T. Neri, T. Gioia, M. Iorio, R. Vanacore, P. Paggiaro, A. Celi (Pisa, PI, Italy)
|   |
Is comorbidity a good prognostic factor for malignant pleural mesothelioma?
U. Gonlugur, T. Gonlugur (Sivas, Turkey)
| |
Periostin is a potent molecular regulate the growth of lung cancer cell line in response to mechanical loading
D. Ma, Q. Zeng, H. Lu, L. Xu, W. Xiao (Jinan, Shandong, China; Kansas City, MO, United States Of America)
| |
Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line
C. Wohlkoenig, K. Leithner, Y. Li, B. Tang, E. Stacher, A. Olschewski, H. Olschewski (Graz, Austria)
| |
Prognostic significance of MUC1 expression in resected lung adenocarcinoma
S. Battal, H. Bayiz, F. Demirag, N. Mutluay, N. Basay, B. Berktas, M. Berkoglu (Ankara, Turkey)
| |
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
M. Petrovic, N. Ilic, Z. Lazic, I. Cekerevac, V. Radulovic (Kragujevac, Belgrade, Serbia And Montenegro)
| |
Prognosis of patients with NSCLC undergoing positive pleural lavage cytology
H. Oma, M. Mitsuoka, K. Nagamine, T. Sakuragi (Saga/Saga, Sasebo/Nagasaki, Japan)
| |
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
J. A. Huang, X. D. Lu, X. L. Zhu, C. Chen, G. B. Zhang, X. G. Zhang (Suzhou,Jiangsu, China)
| |
Alpha and beta estrogen and progesterone receptors expression in non-small cell lung cancer patients
E. Radzikowska, R. Langfort, D. Giedronowicz, M. Chabowski, K. Roszkowski (Warsaw, Poland)
| |
Serum levels of angiopoietin-1, angiopoietin-2 and their receptor- Tie-2 in patients with non small cell lung cancer during chemotherapy
W. Naumnik, E. Chyczewska, M. Ossolinska (Bialystok, Poland)
| |
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results
F. Economidou, K. Antoniou, G. Soufla, A. Proklou, R. Lymbouridou, G. Maltezakis, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
Female sex as prognostic factor in lung cancer
N. Lalic, J. Stanic, A. Tepavac, T. Djeric, B. Zaric (Sremska Kamenica, Serbia And Montenegro)
| |
Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer
M. Okamoto, K. Azuma, H. Imaoka, J. Ikeda, S. Takamori, K. Ohshima, T. Hoshino, T. Iwanaga, H. Aizawa (Kurume, Fukuoka, Japan)
| |
Bcl-2, Bcl-xl, and pp32/PHAPI in resected non-small-cell lung cancer patients
L. H. Schmidt, A. Kuemmel, M. Schuler, S. Biesterfeld, A. Faldum, M. Sebastian, C. Taube, R. Buhl, R. Wiewrodt (Mainz, Essen, Germany)
| |
Pregnancy-associated plasma protein A (PAPP-A) and lung cancer
I. Bulut, A. Coskun, A. Ciftci, E. Cetinkaya, G. Altiay, T. Caglar (Kutahya, Duzce, Agri, Istanbul, Edirne, Turkey)
| |
Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
E. Radzikowska, M. Szolkowska, D. Giedronowicz, D. Gawryluk, K. Roszkowski (Warsaw, Poland)
| |
Immunohistochemical detection of HSP70 Α1Β in different variants of lung cancer
E. Kogan, E. Rudenko, N. Kovalenko, D. Jdanov (Moscow, Russian Federation)
| |
Survival of patients operated for stage I non-small-cell lung cancer
D. Bursac, N. Secen, D. Sazdanic-Velikic, M. Kakas, V. Canak (Sremska Kamenica, Serbia And Montenegro)
| |
Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis
P. D. C. Souza, E. R. Parra, W. Teodoro, T. Takagaki, N. Yoshinari, V. L. Capelozzi (São Paulo, Brazil)
| |
Alpha-1 antitrypsin (AAT) and alpha-2 macroglobulin (AMG) levels according to the stages and histological types in lung cancer
M. Gassaloglu, I. Karasu, A. Ozsoz, G. Senol (Izmir, Turkey)
| |